NASDAQ:EDSA

Edesa Biotech Stock Forecast

etoro logo Buy EDSA
*Your capital is at risk
$4.94
-0.430 (-8.01%)
At Close: Jun 09, 2026
AI Analysis AI Analysis of EDSA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add EDSA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Edesa Biotech, Inc. stock price on Tuesday moving 22.59% between high and low
(Updated on Jun 09, 2026)

Sell candidate since May 22, 2026 Loss -52.77%

The Edesa Biotech, Inc. stock price fell by -8.01% on the last day (Tuesday, 9th Jun 2026) from $5.37 to $4.94. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 22.59% from a day low at $4.56 to a day high of $5.59. The price has fallen in 7 of the last 10 days and is down by -49.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -8 thousand shares and in total, 293 thousand shares were bought and sold for approximately $1.45 million.

Given the current short-term trend, the stock is expected to rise 30.28% during the next 3 months and, with a 90% probability hold a price between $6.44 and $26.44 at the end of this 3-month period.

EDSA Signals & Forecast

There are few to no technical positive signals at the moment. The Edesa Biotech, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.18 and $11.05. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 30, 2026, and so far it has fallen -72.97%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Edesa Biotech, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $1.03 between high and low, or 22.59%. For the last week the stock has had daily average volatility of 22.57%.

Edesa Biotech, Inc. is oversold on RSI14 (5). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EDSA) For The Upcoming Trading Day Of Wednesday 10th

For the upcoming trading day on Wednesday, 10th we expect Edesa Biotech, Inc. to open at $5.03, and during the day (based on 14 day Average True Range), to move between $4.17 and $5.71, which gives a possible trading interval of +/-$1.54 (+/-36.87%) up or down from last closing price. If Edesa Biotech, Inc. takes out the full calculated possible swing range there will be an estimated 36.87% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.12, some $0.180 (3.64%) from the current price of $4.94, our system finds the risk reward not very attractive.

Is Edesa Biotech, Inc. stock A Buy?

The Edesa Biotech, Inc. stock holds several negative signals and despite the positive trend, we believe Edesa Biotech, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.406 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 10, 2026 - $5.03 ( 1.82%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

EDSA Performance

Trading levels for EDSA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.06 22.67%
R2 5.67 14.71%
R1 5.42 9.79%
Price 4.94
S1 4.64 -6.14%
S2 4.39 -11.06%
S3 4.00 -19.03%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.86 18.62%
R2 5.46 10.53%
R1 5.12 3.64%
Price 4.94
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Edesa Biotech, Inc. Stock and on which exchange is it traded?
The symbol for Edesa Biotech, Inc. is EDSA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Edesa Biotech, Inc. Stock?
The Edesa Biotech, Inc. stock holds several negative signals and despite the positive trend, we believe Edesa Biotech, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Edesa Biotech, Inc. Stock?
Edesa Biotech, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Edesa Biotech, Inc. Stock.

What's the current price of Edesa Biotech, Inc. Stock?
As of the end of day on the Jun 09, 2026, the price of an Edesa Biotech, Inc. (EDSA) share was $4.94.

What is the 52-week high and low for Edesa Biotech, Inc. Stock?
The 52-week high for Edesa Biotech, Inc. Stock is $20.32 and the 52-week low is $0.720.

What is the market capitalization of Edesa Biotech, Inc. Stock?
As of the Jun 09, 2026, the market capitalization of Edesa Biotech, Inc. is 43.926M.

When is the next earnings date for Edesa Biotech, Inc.?
The upcoming earnings date for Edesa Biotech, Inc. is Aug 14, 2026.
Click to get the best stock tips daily for free!
ABOUT EDESA BIOTECH, INC.
Edesa Biotech
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chro...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
7.38% Jun 05
TPR
$140.47
3.67% Jun 04
N
NVRI
$19.53
8.19% May 20
SAP
$172.39
3.79% May 05
GLBE
$31.61
2.44% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE